eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0079744|diffuse large b-cell lymphoma |
| Sentences | 2 |
| PubMedID- 22563760 | Impact of rituximab on stem cell mobilization following acvbp regimen in poor-risk patients with diffuse large b-cell lymphoma: results from a large cohort of patients. |
| PubMedID- 24752517 | The combination of rituximab and cyclophosphamide, doxorubicin, vincristine and prednisone is the standard first-line treatment regimen in patients with diffuse large b-cell lymphoma (dlbcl); however, the available data do not apply to elderly or frail patients. |
Page: 1